Sitemap > Clinical Trials > Neurodegenerative & Neuroelectrophysiological Disorders
- TYSABRI® Global Observational Program in Safety
- A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
- Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease
- Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects
- Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males
- Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis
- Pilot Study of Teriflunomide as Adjunctive Therapy to Interferon-β in Subjects With Multiple Sclerosis
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
- Combination Treatment of Relapsing-Remitting Multiple Sclerosis With Methylprednisolone and Interferon-Beta-1a
- Simvastatin as an Add-on Treatment to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
- Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
- Study Evaluating ACC-001 in Mild to Moderate Alzheimer
- Study to Evaluate the Effect of Megestrol Acetate in the Weight Loss in Alzheimer Disease
- A Study of MK0657 in Parkinsons
- Natalizumab High Titer Immunogenicity and Safety
- Avonex 15 Year Long Term Follow-up Study
- A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
- Safety and Tolerability of Long-Term Treatment by Rivastigmine Transdermal Patch in Patients With Probable Alzheimer
- A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
- Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
- A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population
- Autologous Bone Marrow Stem Cells in Ischemic Stroke.
- A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
- BENEFIT Extension Study
- Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)
- Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
- The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer
- Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's disease
- Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer
- A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
- Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer
- Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer
- Open-Label Extension Study of 23mg Donepezil SR in Patients With Moderate to Severe Alzheimer
- ELND005 in Patients With Mild to Moderate Alzheimer
- Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)
- A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencepholgram (EEG) Response in Patients With Photosensitive Epilepsy
- Memory and Insulin in Early Alzheimer
- Efficacy and Safety of AFQ056 in Reducing L-Dopa Induced Dyskinesias in Parkinson
- Effect of AQW051 in Patients With Memory Impairment
- Keppra IV for the Treatment of Motor Fluctuations in Parkinson
- Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson
- Pregabalin (Lyrica) for the Treatment of Essential Tremor
- Effect of LY451039 on the Long Term Progression of Alzheimer's disease
- Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
- A Phase I, Single Dose Study of PF-04360365 in Japanese Patients With Mild to Moderate Alzheimer's Disease
- Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy
- Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity (Best PK/PD)
- Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-Induced Dyskinesia
- Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer
- Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
- Long-Term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-Severe Dementia Associated With Parkinson
- Safety Study of CTS21166 to Treat Alzheimer Disease
- A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-Daily 10 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer
- Combination Therapy Using Cellcept and Rebif in RRMS
- 12-Week Safety Evaluation of Oral CS 0777 in Multiple Sclerosis Patients
- Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
- Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
- Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression
- Efficacy and Safety of Memantine for Parkinsons Disease Dementia (PDD) and Dementia With Lewy Bodies
- The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
- Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures
- Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
- Atacicept in Multiple Sclerosis, Phase II
- Ofatumumab Dose-Finding in RRMS Patients
- Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
- Study of Memantine to Treat Huntingtons Disease
- Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinsons disease
- Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL201)
- REGENESIS: A Phase II Prospective, Randomized, Double-Blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
- A Study of Treatment With ACR16 in Patients With Huntington's Disease
- Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimers Disease
- A Study of the Safety of PAZ-417 in Healthy Elderly Adults
- A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease
